CD44 and hepatocellular carcinoma: In addition to EpCAM, a number of other biomarkers, such as CD133, CD44, CD24 and CD13, have been reported as biomarkers of HCC cancer stem cells, and it would be highly interesting to characterize cultured 3D spheroids for these stem cell markers in future studies.